Skip to main content
. 2022 Jun 14;49(6):379–387. doi: 10.1159/000524250

Table 2.

Agreement of qualitative pre- and post-mortem serological test results of the examined assays

Assay Agreement of qualitative pre- and post-mortem test results*
HBsAg 91.2% (62/68) (81.8–96.7% 95% CI)
anti-HBc 98.4% (63/64) (91.6–100% 95% CI)
anti-HBs 96.2% (51/53) (87–99.5% 95% CI)
anti-HCV 100% (60/60) (95.1–100% 95% CI)
anti-HIV 100% (62/62) (95.3–100% 95% CI)
anti-HTLV 1/2 100% (61/61) (95.2–100% 95% CI)
anti-T. pallidum 100% (66/66) (95.6–100% 95% CI)
*

Irrespective of spiking and used matrix (serum or plasma).